The World Health Organization (WHO) assesses that the EG.5 lineage, which derives from the XBB.1.9.2 variant, does not present a substantial risk.
Global Spread of EG.5 Variant: A GISAID Data Snapshot
As of August 7, around 7,354 sequences of EG.5 have been submitted to GISAID (Global Initiative on Sharing All Influenza Data) (1✔ ✔Trusted SourceEG.5 Initial Risk Evaluation
Go to source) from 51 countries.According to WHO, the largest portion of EG.5 sequences are from China (30.6 percent, 2247 sequences).The other countries with at least 100 sequences are the US (18.4 percent, 1356 sequences), the Republic of Korea (14.1 percent, 1040 sequences), Japan (11.1 percent, 814 sequences), Canada (5.3 percent, 392 sequences), Australia (2.1 percent, 158 sequences), Singapore (2.1 percent, 154 sequences), the UK (2.0 percent, 150 sequences), France (1.6 percent, 119 sequences), Portugal (1.6 percent, 115 sequences), and Spain (1.5 percent, 107 sequences).
COVID Cases Spike Up In UK!
The UK Health Security Agency (UKHSA) reveals that 1 in 7 new COVID cases in the UK are caused by the recently identified variant EG.5.1.
The UK Health Security Agency (UKHSA) reveals that 1 in 7 new COVID cases in the UK are caused by the recently identified variant EG.5.1.
‘EG.5 is a lineage descendant of XBB.1.9.2, sharing the same spike amino acid profile as XBB.1.5. The strain was initially identified on February 17, 2023, and later categorized as a variant under monitoring (VUM) on July 19, 2023. #COVID-19 #COVIDVariant’
"Based on the available evidence, the public health risk posed by EG.5 is evaluated as low at the global level," WHO stated, adding that the risk appeared to be comparable to that of other circulating variants of interest. "While EG.5 has shown increased prevalence, growth advantage, and immune escape properties, there have been no reported changes in disease severity to date," it added.As with Omicron, the most common symptoms of EG.5.1 include runny nose, headache, fatigue (mild or severe), sneezing and sore throat, as per the Zoe Study app.
Reference:
- EG.5 Initial Risk Evaluation - (https://www.who.int/docs/default-source/coronaviruse/09082023eg.5_ire_final.pdf?sfvrsn=2aa2daee_1)
UKHSA Raises Alarm Over Rapidly Spreading 'Eris' Variant of COVID-19
The UK Health Security Agency (UKHSA) has expressed worry about a new form of COVID-19 that is quickly spreading.
The UK Health Security Agency (UKHSA) has expressed worry about a new form of COVID-19 that is quickly spreading.
COVID in Children
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.
Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to ...
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to ...
